CXL PLUS proved to be a successful procedure to halt progression (mainly by CXL) and to correct the refractive status of the keratokonic eye(mainly by ICRS). CXL PLUS performed a synergestic action correcting and mantaining the correction of both myopic and astigmatic components of keratoconus. This study proved thar keraring implantation is more effective in lowering the astigmatic component of KC than the myopic component. This study recorded KC progression in 14% of cases following CXL PLUS with the accelerated epithelium-on CXL so that it is recommended to perform new prospective comparative studies in the future comparing both epithelium-on CXL and epithelium-off CXL procedures in CXL PLUS for the treatment of keratoconus.